RuMedical Nova Secures Breakthrough Sensing Technology from UT Austin

RuMedical Nova has proudly licensed a cutting-edge sensing technology from The University of Texas at Austin—a top-tier innovation powerhouse and birthplace of 31 startup unicorns.

Born from the lab of Dr. D. Emma Fan, RuMedical Nova is on a mission to revolutionize early-stage lung cancer diagnosis with a breakthrough solution that is fast, user-friendly, and exceptionally accurate. This next-generation technology is built on Dr. Fan’s patented biochemical sensing platform, developed at UT Austin and now poised to make real-world impact. RuMedical Nova was launched through the prestigious National Science Foundation I-CORPS program, with a mission to bring next-generation diagnostic tools from lab to life.